SSRgenotyper: A new tool to digitally genotype simple sequence repeats
Scienmag
FEBRUARY 4, 2021
SSRgenotyper: A simple sequence repeat genotyping application for whole-genome resequencing and reduced representational sequencing projects.
Scienmag
FEBRUARY 4, 2021
SSRgenotyper: A simple sequence repeat genotyping application for whole-genome resequencing and reduced representational sequencing projects.
Medical Xpress
JANUARY 5, 2023
National Institutes of Health researchers have published an assessment of 13 studies that took a genotype-first approach to patient care. This approach contrasts with the typical phenotype-first approach to clinical research, which starts with clinical findings.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioTech 365
JUNE 14, 2021
Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening — Population Genetics Sequencing Panel Incorporates … Continue reading (..)
XTalks
NOVEMBER 10, 2020
For more information on tackling this “genomic analysis bottleneck,” watch this on-demand webinar. HS: Due to the heterogeneity of the rare disease population, there are many relevant gene lists, and the genomic data analysis of these patients covers almost 2,000 different genetic targets.
Scienmag
JANUARY 13, 2021
To discover these associations, researchers need to compare the genomes of many individuals at millions of genetic locations or markers, and therefore require cost-effective genotyping technologies. A new statistical method, developed […].
BioTech 365
OCTOBER 28, 2021
NRGene Accelerates Growth with a New Office and Genotyping Lab in Canada NRGene Accelerates Growth with a New Office and Genotyping Lab in Canada SASKATOON, Canada, & NESS ZIONA, Israel–(BUSINESS WIRE)–#agriculture–NRGene (TASE: NRGN), a leading genomics company, announces the official … Continue reading →
pharmaphorum
JANUARY 18, 2023
However, the Resilience Project’s scientists had used genomic data originally collected for other studies and, due to limitations in the original studies’ informed consent policies and a lack of infrastructure to recontact participants, none of the 13 individuals could be contacted with follow-up questions or requests.
Let's personalize your content